![Leonard W. Seymour](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leonard W. Seymour
President bij
British Society for Gene & Stem Cell Therapy
Profiel
Leonard W.
Seymour is the founder of Hybrid BioSystems Ltd. which was founded in 2001.
He held the title of Director in 2010.
Currently, he is the Head-Clinical Pharmacology at the University of Oxford and the President of the British Society for Gene & Stem Cell Therapy.
Actieve functies van Leonard W. Seymour
| Bedrijven | Functie | Begin |
|---|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 04-12-2009 |
British Society for Gene & Stem Cell Therapy | President | 04-12-2009 |
Eerdere bekende functies van Leonard W. Seymour
| Bedrijven | Functie | Einde |
|---|---|---|
Hybrid BioSystems Ltd.
 Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Oprichter | 15-12-2010 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Commercial Services |
British Society for Gene & Stem Cell Therapy |
